Logo.jpg
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2024 INVESTOR CONFERENCE
May 28, 2024 16:07 ET | UMH Properties, Inc.
FREEHOLD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), today announced that the Company will participate in Nareit’s REITweek: 2024 Investor Conference, to be...
clarus_final_indentity.jpg
Clarus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial and Operating Results
March 29, 2022 16:05 ET | Clarus Therapeutics Holdings, Inc.
NORTHBROOK, Ill., March 29, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by...
BEI_ONC_4C_FlatLogo_Horizontal.jpg
BeiGene to Webcast an Analyst and Investor Event from the American Society of Hematology Annual Meeting
December 04, 2017 16:05 ET | BeiGene, LTD.
CAMBRIDGE, Mass., and BEIJING, China, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
BEI_ONC_4C_FlatLogo_Horizontal.jpg
BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences
August 31, 2016 16:15 ET | BeiGene, LTD.
WALTHAM, Mass., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology...